Mineralys Therapeutics (MLYS)'s 30-day implied volatility (IV30) was 68.5% at the close on November 20, 2026, up from 67.2% the day before, against a 52-week range of 40.5% to 131.5%. Its 20-day historical volatility was 73.5%.
Data as of November 20, 2026.